Non-immunosuppressive treatment for IgA nephropathy-Reference-Cited by-同舟云学术

Non-immunosuppressive treatment for IgA nephropathy

Published:2024-02-01 Issue:2 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tunnicliffe David J¹,Reid Sharon²,Craig Jonathan C³⁴,Samuels Joshua A⁵,Molony Donald A⁶,Strippoli Giovanni FM³⁷

Affiliation:

1. Sydney School of Public Health; University of Sydney; Sydney Australia

2. Central Clinical School, Faculty of Medicine and Health; University of Sydney; Sydney Australia

3. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

4. College of Medicine and Public Health; Flinders University; Adelaide Australia

5. Division of Pediatric Nephrology and Hypertension; UT-Houston Health Science Center; Houston TX USA

6. Internal Medicine; UT-Houston Health Science Center; Houston TX USA

7. Department of Emergency and Organ Transplantation; University of Bari; Bari Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Reference362 articles.

1. The effect of diphenylhydantoin on IgA nephropathy;Adamkova;Casopis Lekaru Ceskych,1989

2. The effect of fish oil in patients with IgA nephropathy and renal function impairment: a prospective study [abstract no: A0468];Alexopoulos;Journal of the American Society of Nephrology,2001

3. Treatment of severe IgA nephropathy with omega-3 fatty acids: the effect of a "very low dose" regimen;Alexopoulos;Renal Failure,2004

4. Treatment of severe IgAN with omega-3 fatty acids: the effect of a "very lose dose" regime [abstract no: O92];Alexopoulos;Nephrology Dialysis Transplantation,2002

5. The effect of fish-oil in the treatment of IGA nephropathy (IGAN) [abstract];Stangou;Nephrology Dialysis Transplantation,2001